Events
Global Blood Therapeutics, Inc. and the Sickle Cell Disease Association of America, Inc. announced that they will host the 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference on Tuesday, September 10, 2019, at The Westin Washington, D.C. U.S. Representative Robin Kelly, chair of the Congressional Black Caucus Health Braintrust, will deliver the keynote address.
Akari Therapeutics, Plc announced that Clive Richardson, Chief Executive Officer, will participate and host investor meetings at the following September Conferences:
TLC announced that the Company’s management team has been invited to participate in the BTIG Pain Management Forum on September 11, 2019, where TLC will present data on TLC599 and TLC590.
Helping Health Professionals Combat The Vaccine Hesitancy Crisis
Overdose Awareness Day – Participants will march from Harm Reduction Action Center to the Rita Bass EMS Education building on the Denver Health campus in observance of International Overdose Awareness Day.
Ultragenyx Pharmaceutical Inc. announced that Shalini Sharp, the company’s Chief Financial Officer, will present at the following conferences
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Bittium Exhibits Its Cardiac Monitoring Products and Solutions at ESC Congress 2019
The Award recognizes Patient Entrepreneurs demonstrating outstanding innovations which advance solutions in the prevention, management or care of cancer
Neos Therapeutics, Inc. announced that Jerry McLaughlin, Chief Executive Officer, will present a company overview at two upcoming conferences in September
PRESS RELEASES